The increase in concern about rubella in Nigeria is not due to a brand-new outbreak, but rather the alarming convergence of long-standing low vaccination coverage, recent major outbreaks, and the ...

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte ...

In the Berkshires, pollen season begins late spring with high levels of birch, oak, maple and pine microspores filling the ...

Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...

The UK banned the use of home‑donated plasma in 1998 over fears it could transmit variant Creutzfeldt–Jakob disease (vCJD), the human form of "mad cow disease", which led the NHS to rely on imported ...

Anti-VEGF use for ROP is expanding beyond bevacizumab and ranibizumab, with aflibercept’s fusion-protein structure conferring systemic exposure characteristics distinct from antibody-based agents.

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and metabolic factors.

A shot that keeps a mare from getting pregnant sounds simple. In practice, it is one of the messier problems in wildlife management, where every extra dose means another chase, another dart, another ...

True IgE-mediated local anesthetic hypersensitivity is <1% of reported reactions, so risk reduction should prioritize preservative-free amide selection, minimal effective dosing, and strict avoidance ...

AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections ...